Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Sorensen

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The Journal of the Acoustical Society of America|September 1, 1977
Fundamental frequency contours at syntactic boundariesW E Cooper, J M Sorensen
Cognition|June 1, 1978
Speech timing of grammatical categoriesJ M Sorensen, W E Cooper, J M Paccia
Oncology (Williston Park, N.Y.)|June 1, 1996
Clinical trials referral resource. Clinical trials using gemcitabineJ M Sorensen, P H Phillips, B D Cheson
The Journal of the Acoustical Society of America|April 1, 1977
Correlations of duration for nonadjacent segments in speech: aspects of grammatical codingW E Cooper, J M Sorensen, J M Paccia
Oncology (Williston Park, N.Y.)|July 1, 1996
Clinical trials referral resource. Clinical trials with tomudexJ M Sorensen, B D Cheson, P H Phillips
Leukemia & Lymphoma|July 28, 2016
Current Status of U.S. Clinical Trials in Chronic Lymphocytic LeukemiaB D Cheson, D A Vena, J M Sorensen, et al.
Investigational New Drugs|August 1, 1991
Clinical use of thymidine as a rescue agent from methotrexate toxicityJ L Grem, S A King, J M Sorensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Neurotoxicity of purine analogs: a reviewB D Cheson, D A Vena, F M Foss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemiaB D Cheson, J N Frame, D Vena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up reportJ M Sorensen, D A Vena, A Fallavollita, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The Journal of the Acoustical Society of America|September 1, 1977
Fundamental frequency contours at syntactic boundariesW E Cooper, J M Sorensen
Cognition|June 1, 1978
Speech timing of grammatical categoriesJ M Sorensen, W E Cooper, J M Paccia
Oncology (Williston Park, N.Y.)|June 1, 1996
Clinical trials referral resource. Clinical trials using gemcitabineJ M Sorensen, P H Phillips, B D Cheson
The Journal of the Acoustical Society of America|April 1, 1977
Correlations of duration for nonadjacent segments in speech: aspects of grammatical codingW E Cooper, J M Sorensen, J M Paccia
Oncology (Williston Park, N.Y.)|July 1, 1996
Clinical trials referral resource. Clinical trials with tomudexJ M Sorensen, B D Cheson, P H Phillips
Leukemia & Lymphoma|July 28, 2016
Current Status of U.S. Clinical Trials in Chronic Lymphocytic LeukemiaB D Cheson, D A Vena, J M Sorensen, et al.
Investigational New Drugs|August 1, 1991
Clinical use of thymidine as a rescue agent from methotrexate toxicityJ L Grem, S A King, J M Sorensen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Neurotoxicity of purine analogs: a reviewB D Cheson, D A Vena, F M Foss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemiaB D Cheson, J N Frame, D Vena, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up reportJ M Sorensen, D A Vena, A Fallavollita, et al.
Pageof 2